Analysis
To SBO or IPO, that is the question
Recent evidence has shown that for good companies the barren exit market of last year has been replaced by a tug-of-war between viable divestment routes, writes Emanuel Eftimiu
Q&A: Early-stage evolution
Bart Diels, partner at Belgian investor Gimv, speaks to Francinia Protti-Alvarez about how the venture market in the Benelux region has adapted to the changing economic climate.
Q&A: The fundraising fulcrum
Francois Rowell speaks to Mounir Guen, CEO of placement agent MVision, about the fundraising climate in 2010.
Trimming down: Northzone reflects new reality for venture funds
While the newly-launched Northzone fund is in many ways a rare success for European venture fundraising in the current market, its modest target reflects the continuing difficulties in securing commitments. By Rikke Eckhoff.
Q&A: Germany remains strong at the core
Mareen Goebel speaks to Richard Burton, PricewaterhouseCooper's private equity leader for Germany, about the challenges facing the country's private equity market in the year ahead.
No go for IPOs as New Look compounds listless week
While talk is still ongoing regarding the flurry of GPs signaling their intention to list portfolio companies, many are already postponing plans as prices fall far below expectations. Francois Rowell reports
Q&A: Hungry for secondaries
The secondaries team of NorgesInvestor is aggressively chasing opportunities in the Nordic region. Rikke Eckhoff asks partner Dylan Wolff how he sees the secondaries market.
Q&A: Spain's evasive buyout market
The Spanish buyout market has had to jump over many hurdles these past couple of years. Francinia Protti-Alvarez speaks to José Angel Sarasa, president and CEO at Baring Private Equity Partners España, on its present state and future challenges.
Q&A: Reaching the mezzanine level
Armada Mezzanine recently spun out of Eqvitec. Rikke Eckhoff catches up with managing partner Pertti Nurmio.
California mis-places the agents
CalPERS, CalSTERS trickier to access т but for the wrong reasons, reports Kimberly Romaine
Europe's most promising market
CEE punched above its weight in 2009. Kimberly Romaine comments.
Strong research bodes bright future for Dutch venture
The Netherlands’ excellence in the fields of ICT and Life Sciences is driving dealflow up and prompting optimism for the future. By Francinia Protti-Alvarez
Water investing: money on tap?
Water is back on tap as two companies in the area have generated interest from private equity this week, reports Deborah Sterescu.
AXA's Spotless sale points to return of competitive auction
In the last year the competitive auction has become a rarity, as buyers became unwilling to bid up prices and sought extensive exclusivity. Now, though, they could be back on the cards.
Italy's solar market heats up
Earlier this week UK-based investor Amplio Group connected two solar PV plants in Italy and plans to connect an additional four by the end of the month – all in all a €13m deal.
Q&A: Secondary chances
Hanspeter Bader, head of private equity at Unigestion, talks with Mareen Goebel about the secondaries space and current issues with fundraising
BC and AXA's Medica set to become latest listing
French care home business Medicaтs flotation could be a sign that the IPO market is in rude health.
Advent latest to hunt on Warsaw Exchange
Advent's EUR 100m buyout of WsiP marks the second take-private in two months from one of Europe's busiest stock markets. But why are investors choosing Warsaw? Kimberly Romaine reports
Germany's false dawn
A couple of mega-deals mask the Mittelstand’s demise
Secondaries players to fill later-stage gap
A lack of LP appetite has left a void at the later-stage end of the European venture market. Could secondaries players hold the key, asks Emanuel Eftimiu
Survitec deal bodes strong year for buyouts
This week's foursome of sizable buyouts have put Europe on course to reach EUR 40bn for 2010, 50% larger than 2009's dire figure, writes Kimberly Romaine.
SBOs: To Xafinity and beyond
Duke Streetтs sale of employee benefits company Xafinity to Advent International marks the second major secondary buyout in as many days. With the buyout market currently a dichotomy between cash-rich and exit-starved managers, SBOs could be set to rocket....
SBOs replace IPO hopes as KKR snaps up Bridgepoint's Pets at Home
IPO maths don't add up as KKR completes ТЃ 950m Pets at Home secondary. Rikke Eckhoff reports.